HomeCLGN • NASDAQ
add
Collplant Biotechnologies Ltd - ADR
Previous close
$1.50
Day range
$1.40 - $1.54
Year range
$1.35 - $5.48
Market cap
18.41M USD
Avg Volume
191.47K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | 2.06M | 1,996.94% |
Operating expense | 3.52M | -9.45% |
Net income | -1.45M | 65.39% |
Net profit margin | -70.66 | 98.35% |
Earnings per share | — | — |
EBITDA | -1.40M | 65.32% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 10.74M | -53.78% |
Total assets | 17.21M | -43.19% |
Total liabilities | 4.81M | -17.70% |
Total equity | 12.40M | — |
Shares outstanding | 11.45M | — |
Price to book | 1.39 | — |
Return on assets | -22.94% | — |
Return on capital | -25.92% | — |
Cash Flow
Net change in cash
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Net income | -1.45M | 65.39% |
Cash from operations | -1.17M | 64.13% |
Cash from investing | -8.00K | 90.24% |
Cash from financing | — | — |
Net change in cash | -1.17M | 65.96% |
Free cash flow | -696.00K | 63.80% |
About
Founded
2004
Website
Employees
57